{"id":"https://openalex.org/W2898757302","doi":null,"title":"Tryptophan hydroxylase 2 (TPH2) gene variants associated with Attention Deficit Hyperactivity Disorder (ADHD)","display_name":"Tryptophan hydroxylase 2 (TPH2) gene variants associated with Attention Deficit Hyperactivity Disorder (ADHD)","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2898757302","mag":"2898757302"},"language":"en","primary_location":{"id":"mag:2898757302","doi":null,"is_oa":false,"landing_page_url":"https://dissem.in/p/23911281/tryptophan-hydroxylase-2-tph2-gene-variants-associated-with-attention-deficit-hyperactivity-disorder-adhd","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Karen Sheehan","orcid":"https://orcid.org/0000-0003-3901-8534","observed_orcids":["https://orcid.org/0000-0003-3901-8534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Sheehan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3901-8534","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109185195","display_name":"Naomi Lowe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naomi Lowe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051691432","display_name":"Aiveen Kirley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aiveen Kirley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065522345","display_name":"Celine Mullins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celine Mullins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113799049","display_name":"M. Fitzgerald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fitzgerald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106497970","display_name":"Michael Gill","orcid":"https://orcid.org/0000-0003-0206-5337","observed_orcids":["https://orcid.org/0000-0003-0206-5337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Gill","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0206-5337","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5045364106","display_name":"Ziarih Hawi","orcid":"https://orcid.org/0000-0002-0814-9112","observed_orcids":["https://orcid.org/0000-0002-0814-9112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ziarih Hawi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0814-9112","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.39250727,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tryptophan-hydroxylase-2","display_name":"tryptophan hydroxylase 2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tph2-gene","display_name":"TPH2 gene","score":0.8659999966621399},{"id":"https://openalex.org/keywords/genetic-variants","display_name":"genetic variants","score":0.9580000042915344},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.9599999785423279},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9599999785423279},{"id":"https://openalex.org/keywords/genetic-susceptibility","display_name":"genetic susceptibility","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2779999352","wikidata":"https://www.wikidata.org/wiki/Q18049432","display_name":"TPH2","level":5,"score":0.9736135601997375},{"id":"https://openalex.org/C2775951788","wikidata":"https://www.wikidata.org/wiki/Q418293","display_name":"Tryptophan hydroxylase","level":5,"score":0.8497023582458496},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7617031335830688},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5388990640640259},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4332577586174011},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.42375048995018005},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3785928189754486},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3681667447090149},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23088350892066956},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.1201099157333374},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2898757302","doi":null,"is_oa":false,"landing_page_url":"https://dissem.in/p/23911281/tryptophan-hydroxylase-2-tph2-gene-variants-associated-with-attention-deficit-hyperactivity-disorder-adhd","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1981653214","https://openalex.org/W2020200956","https://openalex.org/W2382485859","https://openalex.org/W2130203999","https://openalex.org/W2073786703","https://openalex.org/W3135294288","https://openalex.org/W2020784579","https://openalex.org/W1987498456","https://openalex.org/W2018916797","https://openalex.org/W2376118619"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2018-11-09T00:00:00"}